Cargando…

ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection

Interferon-stimulated gene 15 (ISG15) is a 15-kDa ubiquitin-like modifier that binds to target proteins in a process termed ISGylation. ISG15, first described as an antiviral molecule against many viruses, participates in numerous cellular processes, from immune modulation to the regulation of genom...

Descripción completa

Detalles Bibliográficos
Autores principales: Albert, Manuel, Vázquez, Jesús, Falcón-Pérez, Juan M., Balboa, María A., Liesa, Marc, Balsinde, Jesús, Guerra, Susana
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769738/
https://www.ncbi.nlm.nih.gov/pubmed/36453897
http://dx.doi.org/10.1128/spectrum.03893-22
_version_ 1784854436747673600
author Albert, Manuel
Vázquez, Jesús
Falcón-Pérez, Juan M.
Balboa, María A.
Liesa, Marc
Balsinde, Jesús
Guerra, Susana
author_facet Albert, Manuel
Vázquez, Jesús
Falcón-Pérez, Juan M.
Balboa, María A.
Liesa, Marc
Balsinde, Jesús
Guerra, Susana
author_sort Albert, Manuel
collection PubMed
description Interferon-stimulated gene 15 (ISG15) is a 15-kDa ubiquitin-like modifier that binds to target proteins in a process termed ISGylation. ISG15, first described as an antiviral molecule against many viruses, participates in numerous cellular processes, from immune modulation to the regulation of genome stability. Interestingly, the role of ISG15 as a regulator of cell metabolism has recently gained strength. We previously described ISG15 as a regulator of mitochondrial functions in bone marrow-derived macrophages (BMDMs) in the context of Vaccinia virus (VACV) infection. Here, we demonstrate that ISG15 regulates lipid metabolism in BMDMs and that ISG15 is necessary to modulate the impact of VACV infection on lipid metabolism. We show that Isg15(−/−) BMDMs demonstrate alterations in the levels of several key proteins of lipid metabolism that result in differences in the lipid profile compared with Isg15(+/+) (wild-type [WT]) BMDMs. Specifically, Isg15(−/−) BMDMs present reduced levels of neutral lipids, reflected by decreased lipid droplet number. These alterations are linked to increased levels of lipases and are independent of enhanced fatty acid oxidation (FAO). Moreover, we demonstrate that VACV causes a dysregulation in the proteomes of BMDMs and alterations in the lipid content of these cells, which appear exacerbated in Isg15(−/−) BMDMs. Such metabolic changes are likely caused by increased expression of the metabolic regulators peroxisome proliferator-activated receptor-γ (PPARγ) and PPARγ coactivator-1α (PGC-1α). In summary, our results highlight that ISG15 controls BMDM lipid metabolism during viral infections, suggesting that ISG15 is an important host factor to restrain VACV impact on cell metabolism. IMPORTANCE The functions of ISG15 are continuously expanding, and growing evidence supports its role as a relevant modulator of cell metabolism. In this work, we highlight how the absence of ISG15 impacts macrophage lipid metabolism in the context of viral infections and how poxviruses modulate metabolism to ensure successful replication. Our results open the door to new advances in the comprehension of macrophage immunometabolism and the interaction between VACV and the host.
format Online
Article
Text
id pubmed-9769738
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-97697382022-12-22 ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection Albert, Manuel Vázquez, Jesús Falcón-Pérez, Juan M. Balboa, María A. Liesa, Marc Balsinde, Jesús Guerra, Susana Microbiol Spectr Research Article Interferon-stimulated gene 15 (ISG15) is a 15-kDa ubiquitin-like modifier that binds to target proteins in a process termed ISGylation. ISG15, first described as an antiviral molecule against many viruses, participates in numerous cellular processes, from immune modulation to the regulation of genome stability. Interestingly, the role of ISG15 as a regulator of cell metabolism has recently gained strength. We previously described ISG15 as a regulator of mitochondrial functions in bone marrow-derived macrophages (BMDMs) in the context of Vaccinia virus (VACV) infection. Here, we demonstrate that ISG15 regulates lipid metabolism in BMDMs and that ISG15 is necessary to modulate the impact of VACV infection on lipid metabolism. We show that Isg15(−/−) BMDMs demonstrate alterations in the levels of several key proteins of lipid metabolism that result in differences in the lipid profile compared with Isg15(+/+) (wild-type [WT]) BMDMs. Specifically, Isg15(−/−) BMDMs present reduced levels of neutral lipids, reflected by decreased lipid droplet number. These alterations are linked to increased levels of lipases and are independent of enhanced fatty acid oxidation (FAO). Moreover, we demonstrate that VACV causes a dysregulation in the proteomes of BMDMs and alterations in the lipid content of these cells, which appear exacerbated in Isg15(−/−) BMDMs. Such metabolic changes are likely caused by increased expression of the metabolic regulators peroxisome proliferator-activated receptor-γ (PPARγ) and PPARγ coactivator-1α (PGC-1α). In summary, our results highlight that ISG15 controls BMDM lipid metabolism during viral infections, suggesting that ISG15 is an important host factor to restrain VACV impact on cell metabolism. IMPORTANCE The functions of ISG15 are continuously expanding, and growing evidence supports its role as a relevant modulator of cell metabolism. In this work, we highlight how the absence of ISG15 impacts macrophage lipid metabolism in the context of viral infections and how poxviruses modulate metabolism to ensure successful replication. Our results open the door to new advances in the comprehension of macrophage immunometabolism and the interaction between VACV and the host. American Society for Microbiology 2022-12-01 /pmc/articles/PMC9769738/ /pubmed/36453897 http://dx.doi.org/10.1128/spectrum.03893-22 Text en Copyright © 2022 Albert et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Research Article
Albert, Manuel
Vázquez, Jesús
Falcón-Pérez, Juan M.
Balboa, María A.
Liesa, Marc
Balsinde, Jesús
Guerra, Susana
ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title_full ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title_fullStr ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title_full_unstemmed ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title_short ISG15 Is a Novel Regulator of Lipid Metabolism during Vaccinia Virus Infection
title_sort isg15 is a novel regulator of lipid metabolism during vaccinia virus infection
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9769738/
https://www.ncbi.nlm.nih.gov/pubmed/36453897
http://dx.doi.org/10.1128/spectrum.03893-22
work_keys_str_mv AT albertmanuel isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT vazquezjesus isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT falconperezjuanm isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT balboamariaa isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT liesamarc isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT balsindejesus isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection
AT guerrasusana isg15isanovelregulatoroflipidmetabolismduringvacciniavirusinfection